Clinical Trial: Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
Sponsor and Collaborators
AIDS Malignancy Clinical Trials Consortium
National Cancer Institute (NCI)
Study Chair: Erin G. Reid, MD University of California, San Diego
Principal Investigator: William Wachsman, MD University of California, San Diego
Next post in Lymphoma Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.